Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Enzymatically mediated engineering of multivalent MHC class II-peptide chimeras.

S Casares1, C A Bona, T D Brumeanu

  • 1Department of Microbiology, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, New York, NY 10029, USA.

Protein Engineering
|May 9, 2001
PubMed
Summary

Researchers developed a new enzymatic method to create multivalent major histocompatibility complex (MHC) class II-peptide ligands. These engineered ligands demonstrate enhanced stability and potent T-cell modulation for potential therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A binding event converted into a folding event.

FEBS letters·2003
Same author

Sensitive detection of GM1 lipid rafts and TCR partitioning in the T cell membrane.

Journal of immunological methods·2003
Same author

Structural cooperativity in the SH3 domain studied by site-directed mutagenesis and amide hydrogen exchange.

FEBS letters·2003
Same author

The temperature dependence of the hydrogen exchange in the SH3 domain of alpha-spectrin.

FEBS letters·2002
Same author

Maintenance of size and function of influenza virus hemagglutinin specific transgenic T-cell clone during life.

Journal of cellular and molecular medicine·2002
Same author

pH dependence of the hydrogen exchange in the SH3 domain of alpha-spectrin.

FEBS letters·2002

Area of Science:

  • Immunology
  • Biotechnology
  • Molecular Engineering

Background:

  • Soluble, bivalent major histocompatibility complex (MHC) class II-peptide ligands for T-cell receptor (TCR) were previously engineered.
  • Increased ligand valence correlates with higher avidity for TCRs and enhanced T-cell stimulation potency.
  • Existing ligands exhibit immunomodulatory effects in vitro and in vivo.

Purpose of the Study:

  • To develop a novel enzymatic method for increasing the valence of MHC-peptide ligands.
  • To generate and characterize covalently stabilized tetravalent and octavalent MHC II-peptide ligands.
  • To investigate the immunomodulatory effects of these multivalent ligands on antigen-specific CD4(+) T-cells.

Main Methods:

  • Enzymatic cross-linking of N-glycan moieties on dimeric MHC II-peptide units.

Related Experiment Videos

  • Utilized a flexible, bifunctional polyethylene glycol linker for cross-linking.
  • Generated covalently stabilized tetravalent and octavalent MHC II-peptide ligands.

    • Main Results:

    • Successfully created multivalent MHC II-peptide ligands with enhanced stability.
    • Ligands maintained structural integrity in blood and lymphoid organs for up to 72 hours.
    • Multivalent ligands demonstrated efficient polarization of CD4(+) T-cells towards type 2 differentiation or induced T-cell anergy and apoptosis, depending on TCR/CD4 clustering.

    Conclusions:

    • Enzymatic engineering provides a rational approach to create multivalent MHC-peptide ligands.
    • These multivalent ligands exhibit potent and tunable modulatory effects on antigen-specific T-cells.
    • This strategy holds promise for developing novel therapeutic agents targeting T-cell responses.